RAT Race Begins: FDA Accepting Regenerative Advanced Therapy Designation Requests

As part of a flurry of actions in the waning days of the Obama Administration, FDA formally announced a process for requesting the new “Regenerative Advanced Therapy” designation. Much like the early days of “Breakthrough,” the standards are uncertain for now.

More from US FDA

More from Agency Leadership